Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay

Dichloroacetate (DCA) represents the first targeted therapy for pyruvate dehydrogenase complex deficiency; it is metabolized by glutathione transferase zeta1 (GSTZ1). Variation in the GSTZ1 haplotype is the principal variable influencing DCA kinetics and dynamics in humans. We aimed to develop a sen...

Full description

Saved in:
Bibliographic Details
Published inGenetic testing and molecular biomarkers Vol. 22; no. 4; p. 266
Main Authors Langaee, Taimour, Wagner, Richard, Horne, Lloyd P, Lawson, Lee Ann, Becker, Cecilia, Shahin, Mohamed, Starostik, Petr, Stacpoole, Peter W
Format Journal Article
LanguageEnglish
Published United States 01.04.2018
Subjects
Online AccessGet more information

Cover

Loading…